Status:
COMPLETED
The Effects of FODMAPs in Patients With Irritable Bowel Syndrome
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Patients with Irritable Bowel Syndrome (IBS) often link their symptoms to foods. Interest in dietary management recently increased, including the use of a low FODMAP diet. To investigate relation of ...
Detailed Description
The study is a randomized, double-blind, cross-over trial. The aim is to assess the effects of low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet compared to m...
Eligibility Criteria
Inclusion
- Adult patients with IBS according to Rome IV criteria
Exclusion
- allergy or documented intolerance to food
- severe cardiovascular disease
- severe hepatic disease
- severe neurological disease
- severe psychiatric disease
- celiac disease
- inflammatory bowel diseases
- diabetes
- bowel dysfunction related to previous surgery
- pregnant or lactating women
- use of antibiotics within four weeks before inclusion
- strict avoidance of foods
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05182593
Start Date
February 1 2019
End Date
September 1 2020
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magnus Simren
Gothenburg, Non-US/Non-Canadian, Sweden, 44331